×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Benoit You

18:30
Introduction
 
 
18:35
Prise en charge actuelle du cancer de l’ovaire et intérêt de KELIM
Pr Benoit You
 
18:55
Rôle des lymphocytes infiltrants tumoraux (TIL) et du score de réponse à la chimiothérapie (CRS)
Dr Pierre-Alexandre Just
 
19:15
Intérêt des tests HR et de RAD51
Dr Alexandra Leary
 
 
19:35
Applications pratiques des nouveaux outils et débat/discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-05-18
Last update : 2022-05-20

Suggestions

Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 13th 2022 from 07am to 08:30am (GMT-10)
San Francisco : Tuesday, December 13th 2022 from 09am to 10:30am (GMT-8)
New York : Tuesday, December 13th 2022 from 12pm to 01:30pm (GMT-5)
Buenos Aires : Tuesday, December 13th 2022 from 02pm to 03:30pm (GMT-3)
London / Dublin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT)
Paris / Berlin : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, December 13th 2022 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, December 13th 2022 from 09pm to 10:30pm (GMT+4)
Bangkok : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+7)
Shanghai : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+8)
Tokyo : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+9)
Sydney : Wednesday, December 14th 2022 from 03am to 04:30am (GMT+10)
Wellington : Wednesday, December 14th 2022 from 05am to 06:30am (GMT+12)

Last improvements in advanced ovarian cancer treatment

Trials that have or will impact practices in the management of patients with advanced ovarian cancer

Share
Monday, October 16th 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Monday, October 16th 2023 from 07am to 08:30am (GMT-10)
San Francisco : Monday, October 16th 2023 from 10am to 11:30am (GMT-7)
New York : Monday, October 16th 2023 from 01pm to 02:30pm (GMT-4)
Buenos Aires : Monday, October 16th 2023 from 02pm to 03:30pm (GMT-3)
Reykjavik : Monday, October 16th 2023 from 05pm to 06:30pm (GMT)
London / Dublin : Monday, October 16th 2023 from 06pm to 07:30pm (GMT+1)
Paris / Berlin : Monday, October 16th 2023 from 07pm to 08:30pm (GMT+2)
Istanbul : Monday, October 16th 2023 from 08pm to 09:30pm (GMT+3)
Moscou / Dubaï : Monday, October 16th 2023 from 09pm to 10:30pm (GMT+4)
Bangkok : Tuesday, October 17th 2023 from 12am to 01:30am (GMT+7)
Shanghai : Tuesday, October 17th 2023 from 01am to 02:30am (GMT+8)
Tokyo : Tuesday, October 17th 2023 from 02am to 03:30am (GMT+9)
Sydney : Tuesday, October 17th 2023 from 04am to 05:30am (GMT+11)
Wellington : Tuesday, October 17th 2023 from 06am to 07:30am (GMT+13)

La nouvelle classification des cancers de l’endomètre en pratique

Cycle d'enseignement - Les cancers gynécologiques

Share
Tuesday, February 6th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, February 6th 2024 from 07am to 08:30am (GMT-10)
San Francisco : Tuesday, February 6th 2024 from 09am to 10:30am (GMT-8)
New York : Tuesday, February 6th 2024 from 12pm to 01:30pm (GMT-5)
Buenos Aires : Tuesday, February 6th 2024 from 02pm to 03:30pm (GMT-3)
London / Dublin : Tuesday, February 6th 2024 from 05pm to 06:30pm (GMT)
Paris / Berlin : Tuesday, February 6th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, February 6th 2024 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, February 6th 2024 from 09pm to 10:30pm (GMT+4)
Bangkok : Wednesday, February 7th 2024 from 12am to 01:30am (GMT+7)
Shanghai : Wednesday, February 7th 2024 from 01am to 02:30am (GMT+8)
Tokyo : Wednesday, February 7th 2024 from 02am to 03:30am (GMT+9)
Sydney : Wednesday, February 7th 2024 from 03am to 04:30am (GMT+10)
Wellington : Wednesday, February 7th 2024 from 05am to 06:30am (GMT+12)

HIPEC in Ovarian Cancer - Time for change ?

Share
Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Honolulu : Wednesday, March 20th 2024 from 08am to 09am (GMT-10)
San Francisco : Wednesday, March 20th 2024 from 10am to 11am (GMT-8)
New York : Wednesday, March 20th 2024 from 01pm to 02pm (GMT-5)
Buenos Aires : Wednesday, March 20th 2024 from 03pm to 04pm (GMT-3)
London / Dublin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT)
Paris / Berlin : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Istanbul : Wednesday, March 20th 2024 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, March 20th 2024 from 10pm to 11pm (GMT+4)
Bangkok : Thursday, March 21st 2024 from 01am to 02am (GMT+7)
Shanghai : Thursday, March 21st 2024 from 02am to 03am (GMT+8)
Tokyo : Thursday, March 21st 2024 from 03am to 04am (GMT+9)
Sydney : Thursday, March 21st 2024 from 04am to 05am (GMT+10)
Wellington : Thursday, March 21st 2024 from 06am to 07am (GMT+12)

Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

éclairages du congrès de la SGO

Share
Scroll Up